Trademark Overview

---

On Monday, July 9, 2012, a trademark application was filed for SUITESPACE with the United States Patent and Trademark Office. The USPTO has given the SUITESPACE trademark a serial number of 85671772. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 5, 2020. This trademark is owned by Gallus BioPharmaceuticals, LLC. The SUITESPACE trademark is filed in the Treatment & Processing of Materials Services category with the following description:

CONTRACT MANUFACTURING IN THE FIELD OF PHARMACEUTICALS, PROVIDED IN A DEDICATED AREA OF THE MANUFACTURING FACILITY

General Information

---

Serial Number	85671772
Word Mark	SUITESPACE
Filing Date	Monday, July 9, 2012
Status	710 - CANCELLED - SECTION 8
Status Date	Friday, June 5, 2020
Registration Number	4401883
Registration Date	Tuesday, September 10, 2013
Mark Drawing	4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition Date	NOT AVAILABLE

Trademark Statements

---

Goods and Services	CONTRACT MANUFACTURING IN THE FIELD OF PHARMACEUTICALS, PROVIDED IN A DEDICATED AREA OF THE MANUFACTURING FACILITY
Pseudo Mark	SUITE SPACE

Classification Information

---

International Class	040 - Treatment of materials.
US Class Codes	100, 103, 106
Class Status Code	2 - Sec. 8 - Entire Registration
Class Status Date	Friday, June 5, 2020
Primary Code	040
First Use Anywhere Date	Wednesday, February 29, 2012
First Use In Commerce Date	Wednesday, February 29, 2012

Trademark Owner History

---

Party Name	Gallus BioPharmaceuticals, LLC
Party Type	30 - Original Registrant
Legal Entity Type	16 - Limited Liability Company
Address	St. Louis, MO 63134

---

Party Name	Gallus BioPharmaceuticals, LLC
Party Type	10 - Original Applicant
Legal Entity Type	16 - Limited Liability Company
Address	St. Louis, MO 63134

Trademark Events

---

Event Date	Event Description
Friday, June 5, 2020	CANCELLED SEC. 8 (6-YR)
Monday, September 10, 2018	COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 4, 2017	ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, July 26, 2017	ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, July 19, 2016	TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 10, 2013	REGISTERED-SUPPLEMENTAL REGISTER
Monday, August 5, 2013	LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 30, 2013	ASSIGNED TO LIE
Monday, July 15, 2013	APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Friday, July 12, 2013	TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 12, 2013	CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 12, 2013	TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, May 2, 2013	NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, May 2, 2013	FINAL REFUSAL E-MAILED
Thursday, May 2, 2013	FINAL REFUSAL WRITTEN
Friday, April 26, 2013	TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 26, 2013	CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 26, 2013	TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 31, 2012	NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 31, 2012	NON-FINAL ACTION E-MAILED
Wednesday, October 31, 2012	NON-FINAL ACTION WRITTEN
Tuesday, October 30, 2012	ASSIGNED TO EXAMINER
Monday, July 16, 2012	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 12, 2012	NEW APPLICATION ENTERED IN TRAM

Related Keywords

---

suitespace manufacturing area facility dedicated pharmaceuticals field contract provided